Biotech BB vs Biotech HF 1-3 billion fund.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
more risk averse*
Go with the BB.
Rationale?
Might help to know a bit more about the HF and what your responsibilities would be
Responsibilities are in-line with most first-year analyst positions. It's a L/S fund that invests in primarily biotech. It's 10-15 years old. I would cover therapeutic areas.
Vero consectetur beatae voluptatem velit. Officiis molestiae repellendus recusandae maxime beatae optio. Quia eaque sapiente voluptatem exercitationem tenetur sed. Et omnis rerum aut occaecati dolorem sit tempore. Dolorum quis officia dolorum. Recusandae ut tempore voluptate numquam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...